Company Overview and News
New Delhi: India may not accept international arbitration orders annulling tax demands on British firms Vodafone Plc and Cairn Energy Plc, a senior official has said, adding that the tax department would continue with recovery actions.
New Delhi: Walmart Inc. will comply with any tax demand arising from its purchase of a stake in India’s e-commerce leader, a move that could help the global giant avoid festering litigation that overseas companies such as Vodafone Group Plc face in the South Asian nation.
Copyright © 2018 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service
New Delhi : Vedanta and state-owned ONGC were top bidders on Wednesday for 55 oil and gas blocks offered in India’s maiden open acreage auction that was shunned by domestic private and international energy majors.
A 'retrospective' amendment to the contract for the prolific Rajasthan oil block has put its operator Cairn India in a spot, as it has to shell out more to the government to retain it for another 10 years.
The miner has access to diversified sources of funding, totaling over $10 billion of US dollar bonds since listing and consistently enhancing credit quality.
Mumbai: Tata Petrodyne Ltd, which has put up its six oil and gas blocks for sale, is yet to find interest from buyers, two people aware of the matter said.
New Delhi : The Income Tax Department has seized a further Rs 440 crore of dividend income due to Cairn Energy to recover a part of the Rs 10,247 crore tax demand it had raised on the British firm using a retrospective tax legislation.
Mumbai: Metals and mining giant Vedanta Ltd, the owner of Cairn India Ltd, is revamping the latter’s operations and creating special business units to sharpen the company’s focus on oil and gas, two people aware of the development said.
The government on Thursday pushed back by a month the last date of bidding for a record number of oil and gas blocks to May 2.
3:30 pm Market Closing: The market closed mildly higher amid volatility ahead of two-day US Federal Reserve meeting beginning later in the day.
2:40 pm New Telecom Policy: Union Minister Manoj Sinha said the new telecom policy is almost ready and will be brought in the next session of Parliament after a Cabinet nod.
12:42 pm Market Update: The market continued to trade higher with the Sensex rising more than 100 points and was trading above the 33,000 levels. Investors looked for cues from the two-day US Federal Reserve meeting beginning later in the day.
11:24 am Market Update: The market continued to trade higher with the BSE Sensex rising around 100 points amid volatility ahead of the US Fed's key policy meet that begins later in the day.
10:40 am Buzzing: Shares in India's Canara Bank tumbled more than 5 percent after the country's federal police filed charges against a former chairman of the state-run bank and others over allegations that the officials helped a company defraud the bank of about USD 10.5 million taken in loans over four years ago.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET